within Pharmacolibrary.Drugs.ATC.N;

model N02CC03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.00045,
    adminDuration  = 600,
    adminMass      = 2.5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0024,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.004833333333333333,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N02CC03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Zolmitriptan is a selective serotonin 5-HT1B/1D receptor agonist used for the acute treatment of migraine headaches, with or without aura, in adults. It is approved for use in many countries including the US and Europe.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers, both male and female, following oral administration.</p><h4>References</h4><ol><li><p>Dixon, R, &amp; Warrander, A (1997). The clinical pharmacokinetics of zolmitriptan. <i>Cephalalgia : an international journal of headache</i> 17 Suppl 18 15–20. DOI:<a href=\"https://doi.org/10.1177/0333102497017S1803\">10.1177/0333102497017S1803</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9399013/\">https://pubmed.ncbi.nlm.nih.gov/9399013</a></p></li><li><p>Dixon, RM, et al., &amp; Rolan, PE (1997). Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers. <i>Cephalalgia : an international journal of headache</i> 17(6) 639–646. DOI:<a href=\"https://doi.org/10.1046/j.1468-2982.1997.1706639.x\">10.1046/j.1468-2982.1997.1706639.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9350383/\">https://pubmed.ncbi.nlm.nih.gov/9350383</a></p></li><li><p>Tepper, SJ, et al., &amp; Rapoport, AM (2013). Intranasal zolmitriptan for the treatment of acute migraine. <i>Headache</i> 53 Suppl 2 62–71. DOI:<a href=\"https://doi.org/10.1111/head.12181\">10.1111/head.12181</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24024604/\">https://pubmed.ncbi.nlm.nih.gov/24024604</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N02CC03;
